Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch

Experimental and Clinical Transplantation

Volumn 7, Issue 2, 2009, Pages 124-128

  Mahmoud, Khaled Mohamed ^a   Ismail, Amani Mostafa ^a   Sheashaa, Hussein Attia ^a   Gheith, Osama Ashry ^a   Kamal, Mohamed Mohamed ^a   Ghoneim, Mohamed Ahmed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Crossmatch; Donor specific antibodies; Kidney transplant; Luminex; Rejection

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HLA ANTIBODY; RAPAMYCIN; STEROID; TACROLIMUS; ANTIIDIOTYPIC ANTIBODY; COMPLEMENT; HLA ANTIGEN;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD ANALYSIS; BLOOD GROUP TYPING; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; INCIDENCE; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME; ADOLESCENT; BLOOD; CYTOTOXICITY TEST; DONOR; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; ANTIBODIES, ANTI-IDIOTYPIC; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; YOUNG ADULT;

EID: 70350507487     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Patel AM, Pancoska C,Mulgaonkar S,Weng FL. Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant. 2007;7(10):2371-2377.
2. Gebel HM, Lebeck LK. Crossmatch procedures used in organ transplantation. Clin Lab Med. 1991;11(3):603-620.
3. Kimball P, Rhodes C, King A, Fisher R, Ham J, Posner M. Flow cross-matching identifies patients at risk for postoperative elaboration of cytotoxic antibodies. Transplantation. 1998;65(3):444-446. (Pubitemid 28095981)
4. Bray RA, Nickerson PW, Kerman RH, Gebel HM. Evolution of HLA antibody detection: technology emulating biology. Immunol Res. 2004;29(1-3):41-54.
5. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969;280(14):735-739.
6. Cook DJ, Terasaki PI, Iwaki Y, et al. The flow cytometry crossmatch in kidney transplantation. Clin Transpl. 1987:409-414. (Pubitemid 17025549)
7. Ogura K, Terasaki PI, Johnson C, et al. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation. Transplantation. 1993;56(2):294-298. (Pubitemid 23239427)
8. Worthington JE, Langton A, Liggett H, Robson AJ, Martin S. A novel strategy for the detection and definition of HLA-specific antibodies in patients awaiting renal transplantation. Transpl Int. 1998;11(suppl 1):S372-S376. (Pubitemid 128683582)
9. Zachary AA, Ratner LE, Graziani JA, Lucas DP, Delaney NL, Leffell MS. Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets: II. Clinical relevance. Hum Immunol. 2001;62(3):236-246.
10. Kao KJ, Scornik JC, Small SJ. Enzyme-linked immunoassay for anti-HLA antibodies - an alternative to panel studies by lymphocytotoxicity. Transplantation. 1993;55(1):192-196.
11. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature. 1964;204:998-1000.
12. Feucht HE. Significance of donor-specific antibodies in acute rejection. Transplant Proc. 2005;37(9):3693-3694.
13. Burns JM, Cornell LD, Perry DK, et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant. 2008;8(12):2684-2694.
14. Gupta A, Iveson V, Varagunam M, Bodger S, Sinnott P, Thuraisingham RC. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant? Transplantation. 2008;85(8):1200-1204.
15. Lefaucheur C, Suberbielle-Boissel C, Hill GS, et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant. 2008;8(2):324-331.
16. van den Berg-Loonen EM, Billen EV, Voorter CE, et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation. 2008;85(8):1086-1090.